Status:
COMPLETED
The Potential Impact of Clindamycin on Neurosurgery Patients.
Lead Sponsor:
Damanhour University
Conditions:
Neurologic Complication
Neurosurgery
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
A prospective, open-label, single center, controlled trial. 44 patients that underwent neurosurgery or presented meningitis signs, for whom Clindamycin add-on therapy to assess its effect on neurologi...
Detailed Description
1. This is a prospective, open-label, single center, controlled trial. 44 patients that underwent neurosurgery or presented meningitis signs, for whom Clindamycin add-on therapy is prescribed (900 - 1...
Eligibility Criteria
Inclusion
- Inclusion criteria
- 1\) Adult patients will be enrolled if they underwent neurosurgery or presented with clinical signs of meningitis.
- Exclusion criteria
- Age lower than 18.
- Females with a positive pregnancy test.
- Known congestive heart failure or ischemic heart disease.
- Any injury that disturbs the examination (high cervical cord injury or locked-in syndrome, could be a source of bias).
- Severe brain disease (For example CVA history or brain tumor).
- Renal failure with GFR lower than 60 ml/min.
- Patients with unknown identity.
Exclusion
Key Trial Info
Start Date :
March 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2023
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT06068673
Start Date
March 1 2023
End Date
December 30 2023
Last Update
January 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alexandria University Hospital
Alexandria, Egypt